Wednesday served up a day’s catch like the networks all went to lunch at once and forgot to come back: plenty of offers, even more motion, but when it comes to payouts, not everyone’s sipping the good stuff anymore.

🧪 T-Light gave joints the full treatment

At T-Light, Lithuanian Flexosamine threw itself a little party: 2 offers got repriced from 23–25 to 42–45 (+80…83%). Nutra, as always, “heals” like it just wrote itself a bonus and a box of ampoules on top.

💀 M1 gave nutra an ice-cold shower

M1 in Portugal repriced 11 offers at once — and for almost all of them, things got worse: 35–41 → 26–31. Especially sad for Artrosteel and Adenolex. Yesterday it was still “this is about to fly,” today it’s more like “hold the ice pack and keep quiet.”

🎉 Oziva found the “plus” button again

Indian Oziva New grew on both Repeat user and New user, from 5.16→6.3 and 7.46→9.1 (+22% in both cases). Nutra sure knows how to play it: one minute it’s “health,” the next it’s “reorder,” and in reality it’s just neatly squeezing a couple more rupees out of optimism.

🎉 Retouch4me retouched its own check

For Retouch4me in WW, the subscription jumped from 38.46 to 48 (+25%). Mobile subs look today like they got a light facelift too: no drama, but the wallet’s definitely looking fresher.

🧭 Agoda landed in APAC so nobody gets bored

A new offer made its way in: AGODA APAC from CityAds AP. Travel is once again pretending the world is just a wheeled suitcase and a “book now” button. Let’s see how many GEOs it manages to roll through before it changes its mind.

🧨 M1 picked up speed, while Rafinad got moody

M1 saw a spike in activity to 78 with a median of 5.0 — that’s no longer “a bit of life,” that’s a full-on nutra commotion. Meanwhile, Rafinad in the “getting worse” column is clearly not in the mood for the day: both “Hello, neighbor!” and FINTERS left the stage. A day without fanfare, but with a hint: whoever made the noise, got tired first.